Oxford BioMedica Share Price (OXB)

3.73 -0.10 (-2.61%) delayed: 2:22AM BST
Bid price 3.70 Open price 3.75
Ask price 3.75 Prev close 3.73
High price 3.82 Spread 1.33%
Low price 3.70 Volume 1,785,655

Register now for FREE live Oxford BioMedica share prices, Oxford BioMedica stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Oxford BioMedica Level 2 Data, indepth research tools and investor commentary for Oxford BioMedica (OXB) and other London Stock Exchange equities.

Oxford BioMedica Share Price Chart

Advanced Charts >>

Register now for FREE Oxford BioMedica share price charts

Oxford BioMedica Share Price Information

Name Oxford BioMedica Epic OXB
Sector Pharmaceuticals & Biotechnology ISIN GB0006648157
Activites Oxford BioMedica plc is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Index n/a

Oxford BioMedica Key Numbers

Latest Share Price (p) 3.73 Net Gearing (%) 18.89
Market Capitalisation (£m) 95.54 Gross Gearing (%) 34.79
Shares in issue (m) 2,494.58 Debt Ratio 5.64
P/E Ratio -4.85 Debt-to-Equity Ratio 0.11
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.53
Dividend Yield (%) 0.00 Price to book value 10.73
Dividend cover (x) 0.00 ROCE -1.12
Earning per share (p) -0.79 EPS Growth (%) -3.95
52 week high / low 3.95 / 1.83 DPS Growth (%) n/a

Oxford BioMedica Director Deals

Dec.Date Type Director Pos No. of Shares
01/07/2014 BUY Paul Blake ED 285,000
22/11/2013 BUY Nicholas Rodgers CH 208,000
19/09/2013 BUY Andrew Heath NED 100,000
12/09/2013 BUY Tim Watts FD 400,000
10/06/2013 BUY Paul Blake ED 113,097

More Oxford BioMedica Director Deals >>

Oxford BioMedica Company News

07:00 28/08/2014

Half Yearly Report

/* */ RNS Number : 1550Q Oxford Biomedica PLC 28 August 2014    OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2014   Oxford, UK - 28 August 2014: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), a...

More Oxford BioMedica Company News >>

Register now for FREE Oxford BioMedica company news

Oxford BioMedica Share Price Discussions

8 days ago

CANCER drug co. Oxford Biomedica charts (OXB)

OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles. So here is a new title This one has got the charts at the top again & has a link to the old one....

more than 1 year ago


Very strong rumours of a further predator around. CAT,WYEYH,JOHNSON&JOHNSON,MERCK to name a few.............could be an exciting week ...!

more than 1 year ago


Very strong rumours of a further predator.........CAT,JOHNSON&JOHNSON,WYETH,MERCK to name a few. Could be an interesting week..!

Register now for FREE Oxford BioMedica share price discussions